MIT NEWDIGS Design Lab advances work on medical treatment financing strategies
Industry leaders, patient advocates, and policymakers collaborate to make groundbreaking new therapies economically sustainable.
Industry leaders, patient advocates, and policymakers collaborate to make groundbreaking new therapies economically sustainable.
Researchers have identified a key nutrient sensor in the mTOR pathway that links nutrient availability to cell growth.
Improved methods validate the use of blood samples for studying patients’ cancer genomes.
This year’s clinic lived up to its reputation as one of the most efficient operations at MIT.
Studies by Richard Wurtman have led to development of nutrient mix shown to slow cognitive impairment in early stages of the disease.
Model developed at MIT’s Computer Science and Artificial Intelligence Laboratory could reduce false positives and unnecessary surgeries.
The 2017 Transcatheter Cardiovascular Therapeutics Career Achievement Award honors a pioneering biomedical engineer, scientist, professor, and cardiologist.
Drug already in clinical trials may be effective on some aggressive adenocarcinomas.
Cutting off a process that cancerous cells rely on can force them to stop growing.
Influenza viruses can hijack host cellular machinery to help mutated viral proteins fold and function.
Engineered insulin that can be activated by high blood sugar could improve diabetics’ quality of life.
Microfluidic device uses acoustics to quickly analyze blood for signatures of cancer and other diseases.
Microparticles created by new 3-D fabrication method could release drugs or vaccines long after injection.
Test of cervical mucus may reveal pregnant women’s risk of going into labor too early.
Conceived at an MIT hackathon, system could reduce amputations, cut medical costs for diabetics.